OAC
ALXO icon

OMERS Administration Corp’s ALX Oncology ALXO Stock Holding History

OMERS Administration Corp’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
+75,000
New +$143K ﹤0.01% 959

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

OMERS Administration Corp's ALXO Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in ALX Oncology (ALXO) in Q1 2026: 75,000 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #959 among its holdings.

69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • OMERS Administration Corp held 75,000 shares of ALX Oncology worth $150K as of Q1 2026.
  • ALX Oncology was a new OMERS Administration Corp position in Q1 2026.
  • ALX Oncology made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #959 holding.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.